Sample preparation antibodies

Immunoassays. Immunoassays (qv) maybe simply defined as analytical techniques that use antibodies or antibody-related reagents for selective deterrnination of sample components (94). These make up some of the most powerflil and widespread techniques used in clinical chemistry. The main advantages of immunoassays are high selectivity, low limits of detection, and adaptibiUty for use in detecting most compounds of clinical interest. Because of their high selectivity, immunoassays can often be used even for complex samples such as urine or blood, with Httle or no sample preparation. 

Kennedy et al. developed a lasalocid immunoassay for application to residues in chicken meat and liver samples. The antibody was specific and did not cross-react with salinomycin, maduramicin, or monensin. Sample preparation consisted of homogenization in aqueous acetonitrile, removal of fat from an aliquot of the aqueous acetonitrile by hexane extraction, and evaporation of acetonitrile. The sample was then reconstituted with assay buffer. Liver required an additional solid phase extraction step. The LOQ was 0.02 xgkg for muscle and 0.15 agkg for liver. These workers were able to use the system to determine the half-life of lasalocid in the tissues. 

The increasing attention directed to the adverse effects of variation in sample preparation upon the quality of IHC staining of FFPE tissues has served to reinforce the importance of determining the optimal AR method for each antibody/detection system/antigen to achieve optimal retrieval and optimal staining of tissues that may have been processed and stored in different and unknown ways (see Chapter 5 for details). Practically, in considering... 

Standardization of IHC/ICC has been a critical issue for more than three decades, especially with the advances in targeted therapy such as the development of trastuzumab (Herceptin) for advanced breast cancer.51 Nevertheless, standardization is a difficult issue because numerous factors may influence the consistency and reliability of immunostaining results, including fixatives, fixation time, AR, antibody clones, detection system, and interpretation (see Part II). In cytopathology, the situation is even worse due to its variable cell sample preparation techniques. Cytopreparation is. .. the foundation of cytomorphology. 52 We believe it is also the foundation of ICC. Therefore, standardization of ICC needs to start with uniform and reliable cytopreparation. 

These methods have been used since the 1970s they usually require little or no sample preparation and are rapid and easy to use. However, immunoassay has two limitations. First, it does not differentiate between active drugs and similar molecules such as metabolites or co-administered drugs.9,11 Thus, cross-reactivity is a common problem. Second, its use is limited to only those drugs for which antibodies are available. 

Figure 9.6 Capillary IEF and slab gel IEF of antibodies of rhuMAbHER2. There was good correlation between the number of bands obtained by the two techniques. Notice the excellent resolution of the sample components achieved by CIEF. In this application, the sample was bracketed by synthetic pi markers of known pi that are not only extremely useful in the determination of pi, but can also be used for correction of migration time variations. During methods development, the pi standards can be prepared in ampholytes at a higher concentration (e.g., 10X) and introduced as a second injection after the capillary is first filled with sample prepared in ampholytes. Using this approach, the combination of pi markers can be optimized with a minimal usage of sample (see Reference 112).

The Western blot method is often used in the analysis of host cell impurities. It can be used to identify a recurring impurity. O Keefe et al. used a Western blot to identify an E. coli protein impurity in the preparation of the recombinant fibroblast growth factor (aFGF).29 By using specific antisera to the E. coli host cell proteins, they were able to isolate the impurity and determine its N-terminus amino acid sequence to confirm its identity. Antibodies could be used to determine the concentration of this impurity in sample preparations. 

For standard MALDI sample preparation, the analyte should be soluble to about 0.1 mg ml in some solvent. If an analyte is completely insoluble, solvent-free sample preparation may alternatively be applied (Chap. 10.4.3). The analyte may be neutral or ionic. Solutions containing metal salts, e.g., from buffers or excess of non-complexated metals, may cause a confusingly large number of signals due to multiple proton/metal exchange and adduct ion formation even complete suppression of the analyte can occur. The mass range of MALDI is theoretically almost unlimited in practice, limits can be as low as 3000 u, e.g., with polyethylene, or as high as 300,000 u in case of antibodies. 

Proteins or antibodies (36 pg) were mixed with ampholine pH 3.5—9.5 (final concentration of 5%, Amersham Biosciences, distributed by GE Healthcare, Uppsala, Sweden), p7 markers (Bio-Rad, Hercules, CA), and hydroxypropyl methyl cellulose (final concentration of 0.2% HPMC, Sigma-Aldrich, St. Louis, MO). The final protein concentration was 0.3mg/mL. Figure 17 shows a schematic of the sample preparation. The mixture was mixed thoroughly and was introduced to the capillary (eCAP neutral-coated, 50 micron X 30 cm, Beckman, Fullerton, CA) by hydrodynamic injection. Injections were performed using 20 psi for 99 s. The solution was then separated under an electric field of 25 kV for 10 min. The focused protein was then pushed/pulled out of the capillary through a mobilization process using the cathodic mobilizer (Bio-Rad, Hercules, CA). 

FIGURE I 7 Sample preparation for cIEF analysis of proteins and antibodies. 

In most cases, the sample titer curves followed the predicted titer standard curve based upon known concentration ratios. Observed variations in linearity were traced back to inconsistencies in labeling rather than cross-reactivity or sample preparation issues such as pipetting or mixing errors. Overall, antigen arrays performed better than antibody arrays. While the exact reasons for the... 

Once antibodies and antigens have been developed, they must be incorporated into an assay system for visualization of the primary antibody-antigen reaction. To accomplish this task effectively, an assay format and procedures to visualize the antibody-antigen reaction must be first selected, the necessary reagents must then be prepared, and the final immunochemical method including sample preparation must be optimized for the intended application. 

Matrix Sample preparation Type of immunoassay Antibody Sensitivity Ref. 

---